{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:01:40Z","timestamp":1760122900114},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"62","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2019,11,19]]},"DOI":"10.18632\/oncotarget.27333","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T16:34:53Z","timestamp":1574181293000},"page":"6713-6722","source":"Crossref","is-referenced-by-count":4,"title":["Tumor tissue hnRNP M and HSP 90\u03b1 as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: A proteomics-based study"],"prefix":"10.18632","volume":"10","author":[{"given":"Andro","family":"Ko\u0161ec","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Centre Sestre Milosrdnice, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru\u0111er","family":"Novak","sequence":"additional","affiliation":[{"name":"Department for Proteomics, Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pa\u0161ko","family":"Konjevoda","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, Laboratory for Epigenomics, Rudjer Boskovic Institute, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Trkulja","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Bedekovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Centre Sestre Milosrdnice, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovorka","family":"Grgurevi\u0107","sequence":"additional","affiliation":[{"name":"Department for Proteomics, Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Zagreb, Croatia"},{"name":"Department of Anatomy \u201cDrago Perovi\u0107\u201d, School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5826\/dpc.0702a01","article-title":"Epidemiological trends in skin cancer","volume":"7","author":"Ioannides","year":"2017","journal-title":"Dermatol Pract Concept"},{"key":"2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1245\/s10434-015-4766-y","article-title":"Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity","volume":"23","author":"Karakousis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1245\/s10434-019-07204-2","article-title":"Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma","volume":"26","author":"van Diest","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Flaherty","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ejca.2009.04.016","article-title":"LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)","volume":"45","author":"Eggermont","year":"2009","journal-title":"Eur J Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-018-0757-5","article-title":"Liquid biomarkers in melanoma: detection and discovery","volume":"17","author":"Rizos","year":"2018","journal-title":"Mol Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ijc.21073","article-title":"Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma","volume":"117","author":"Schadendorf","year":"2005","journal-title":"Int J Cancer"},{"key":"8","first-page":"17","article-title":"Identification of melanoma antigens using a Serological Proteome Approach (SERPA)","volume":"7","author":"Kiyohara","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"9","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1200\/JCO.2008.18.0554","article-title":"Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling","volume":"27","author":"Ugurel","year":"2009","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jprot.2011.04.013","article-title":"Protein signatures for survival and recurrence in metastatic melanoma","volume":"74","author":"Caprioli","year":"2011","journal-title":"J Proteomics"},{"key":"11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1755-148X.2010.00774.x","article-title":"Combined mass spectrometry- and immunohistochemistry-based approach to determine protein expression in archival melanoma--proof of principle","volume":"23","author":"Han","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1600-0560.2011.01761.x","article-title":"A quantitative proteomic analysis of FFPE melanoma","volume":"38","author":"Tackett","year":"2011","journal-title":"J Cutan Pathol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ijc.30202","article-title":"Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma","volume":"139","author":"Boyano","year":"2016","journal-title":"Int J Cancer"},{"key":"14","first-page":"189","volume-title":"In Diagnostic and prognostic biomarkers and therapeutic targets in melanoma","author":"Han","year":"2012"},{"key":"15","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1002\/cncr.25245","article-title":"Head and neck cancer: proteomic advances and biomarker achievements","volume":"116","author":"Franco","year":"2010","journal-title":"Cancer"},{"key":"16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jso.25316","article-title":"Current management of regional lymph nodes in patients with melanoma","volume":"119","author":"Bartlett","year":"2019","journal-title":"J Surg Oncol"},{"key":"17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaad.2018.03.023","article-title":"Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study","volume":"79","author":"Robsahm","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"18","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1245\/s10434-016-5196-1","article-title":"Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management","volume":"23","author":"Thompson","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"19","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Glass","year":"2006","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/CMR.0b013e32831993cc","article-title":"Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse","volume":"19","author":"Hauschild","year":"2009","journal-title":"Melanoma Res"},{"key":"21","first-page":"1311","article-title":"S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase","volume":"21","author":"Peter","year":"2001","journal-title":"Anticancer Res"},{"key":"22","first-page":"691","article-title":"MIA, S100 and LDH as important predictors of overall survival of patients with stage IIb and IIc melanoma","volume":"21","author":"Vucinic","year":"2016","journal-title":"J BUON"},{"key":"23","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1021\/pr800745e","article-title":"Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma","volume":"8","author":"Ponten","year":"2009","journal-title":"J Proteome Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.clinbiochem.2012.12.011","article-title":"The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma","volume":"46","author":"Solassol","year":"2013","journal-title":"Clin Biochem"},{"key":"25","doi-asserted-by":"publisher","first-page":"G394","DOI":"10.1152\/ajpgi.00328.2013","article-title":"Identification of HnRNP M as a novel biomarker for colorectal carcinoma by quantitative proteomics","volume":"306","author":"Liu","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"26","doi-asserted-by":"publisher","first-page":"e0179363","DOI":"10.1371\/journal.pone.0179363","article-title":"The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer","volume":"12","author":"Skirnisdottir","year":"2017","journal-title":"PLoS One"},{"key":"27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.biopha.2018.05.014","article-title":"Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin\/\u03b2-catenin signaling pathway","volume":"105","author":"Dai","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/138161213804143725","article-title":"The therapeutic target Hsp90 and cancer hallmarks","volume":"19","author":"Neckers","year":"2013","journal-title":"Curr Pharm Des"},{"key":"29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.22034\/APJCP.2017.18.3.599","article-title":"Clinical significance of circulating serum cellular heat shock protein 90 (HSP90) level in patients with cutaneous malignant melanoma","volume":"18","author":"Duranyildiz","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"30","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Ishihama","year":"2007","journal-title":"Nat Protoc"},{"key":"31","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/pmic.201300135","article-title":"Critical assessment of proteome-wide label-free absolute abundance estimation strategies","volume":"13","author":"Schmidt","year":"2013","journal-title":"Proteomics"},{"key":"32","doi-asserted-by":"publisher","first-page":"D1063","DOI":"10.1093\/nar\/gks1262","article-title":"The Proteomics Identifications (PRIDE) database and associated tools: status in 2013","volume":"41","author":"Ovelleiro","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"33","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2017"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Therneau, Grambsch. Modeling Survival Data: Extending the Cox Model. Springer, New York. ISBN 0-387-98784-3, 2000.","DOI":"10.1007\/978-1-4757-3294-8"},{"key":"35","unstructured":"Therneau, Atkinson, Ripley. rpart: Recursive Partitioning and Regression Trees. R package version 4.1-11. 2017. https:\/\/CRAN.R-project.org\/package=rpart."},{"key":"36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4137\/CIN.S39364","article-title":"Recursive Partitioning Method on Competing Risk Outcomes","volume":"15","author":"Kong","year":"2016","journal-title":"Cancer Inform"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T15:20:58Z","timestamp":1591456858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":36,"journal-issue":{"issue":"62","published-print":{"date-parts":[[2019,11,19]]}},"alternative-id":["27333","31803364"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27333","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]}}}